Lack of evidence for association between endothelial nitric oxide synthase gene polymorphisms and coronary artery disease in the australian caucasian population

European Journal of Cardiovascular Prevention & Rehabilitation

Volumn 8, Issue 4, 2001, Pages 235-241

  Granath, Britt ^a   Taylor, Roger R ^a   Van Bockxmeer, Frank M ^a   Mamotte, Cyril D S ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Coronary Artery Disease; Endothelial Nitric Oxide; Synthase Polymorphism

Indexed keywords

NITRIC OXIDE SYNTHASE;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; AUSTRALIA; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CAUCASIAN; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR;

ADULT; ALLELES; AUSTRALIA; CASE-CONTROL STUDIES; CORONARY ARTERIOSCLEROSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; MALE; NITRIC OXIDE SYNTHASE; POLYMORPHISM, GENETIC; STATISTICS, NONPARAMETRIC;

EID: 0034869098     PISSN: 17418267     EISSN: 17418275     Source Type: Journal    
DOI: 10.1177/174182670100800408     Document Type: Article

References (23)

1. Moncada S, Higgs EA. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 1995; 9: 1319–1330.
2. Harrison DG. Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 1997; 100: 2153–2157.
3. Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DEL. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nature Med 1996; 2: 41–45.
4. Ichihara S, Yamada Y, Fujimura T, Nakashima N, Yokota M. Association of a polymorphism of the endothelial constitutive nitric oxide synthase gene with myocardial infarction in the Japanese population. Am J Cardiol 1998; 81: 83–86.
5. Hooper WC, Lally C, Austin H, Benson J, Dilley A, Wenger NK et al. The relationship between polymorphisms in the endothelial cell nitric oxide synthase gene and the platelet GpIIIa gene with myocardial infarction and venous thrombosis in African Americans. Chest 1999; 116: 880–886.
6. Wang XL, Mahaney MC, Sim AS, Wang J, Wang J, Blangero J et al. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol 1997; 17: 3147–3153.
7. Tsukada T, Yokoyama K, Arai T, Takemoto F, Hara S, Yamada A et al. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Comm 1998; 245: 190–193.
8. Hibi K, Ishigami T, Tamura K, Mizushima S, Nyui N, Fujita T et al. Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension 1998; 32: 521–526.
9. Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Parsons A et al. A common variant of the endothelial nitric oxide synthase (Glu298 ⇉ Asp) is a major risk factor for coronary artery disease in the UK. Circulation 1999; 100: 1515–1520.
10. Yoon Y, Song J, Hong SH, Kim JQ. Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clin Chem 2000; 46: 1626–1630.
11. Sigusch HH, Surber R, Lehmann MH, Surber S, Weber J, Henke A et al. Lack of association between 27-bp repeat polymorphism in intron 4 of the endothelial nitric oxide synthase gene and the risk of coronary artery disease. Scan J Clin Lab Invest 2000; 60: 229–235.
12. Pulkkinen A, Viitanen L, Kareinen A, Lehtos S, Vauhkonen I, Laakso M. Intron 4 polymorphism of the endothelial nitric oxide synthase gene is associated with elevated blood pressure in type 2 diabetic patients with coronary heart disease. J Mol Med 2000; 78: 372–379.
13. Shimasaki Y, Yasue H, Yoshimura M, Nakayama M, Kugiyama K, Ogawa H et al. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 1998; 31: 1506–1510.
14. Poirier O, Mao C, Mallet C, Nicaud V, Herrmann SM, Evans A et al. Polymorphisms of the endothelial nitric oxide synthase gene – no consistent association with myocardial infarction in the ECTIM study. Eur J Clin Invest 1999; 29: 284–290.
15. Liyou N, Simons L, Friedlander Y, Simons J, McCallum J, O'Shaughnessy K et al Coronary artery disease is not associated with the E298 ⇉ D variant of the constitutive, endothelial nitric oxide synthase gene. Clin Genet 1998; 54: 528–529.
16. Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H et al. T-786C mutation in the 5-flanking region of the endothelial nitric oxide synthase gene that is associated with coronary spasm. Circulation 1999; 99: 2864–2870.
17. Sim AS, Wang J, Wilcken D, Wang XL. MspI polymorphism in the promoter of the human endothelial constitutive NO synthase gene in Australian Caucasian population. Mol Genet Metab 1998; 65: 62.
18. Kunkel LM, Smith KD, Boyer SH, Borgaonkar DS, Wachtel SS, Miller OJ et al. Analysis of human Y-chromosome specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA 1977; 74: 1245–1249.
19. Fowkes FGR, Lee AJ, Hau CM, Cooke A, Connor JM, Lowe GDO. Methylene tetrahydrofolate reductase (MTHFR) and nitric oxide synthase (ecNOS) genes and risks of peripheral arterial disease and coronary heart disease: Edinburgh artery study. Atherosclerosis 2000; 150: 179–185.
20. Wever RMF, Luscher TF, Cosentino F, Rabelink TJ. Atherosclerosis and the two faces of endothelial nitric oxide synthase. Circulation 1998; 97: 108–112.
21. Wang XL, Sim AS, Wang MX, Murrell GAC, Trudinger B, Wang J. Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. FEBS Lett 2000; 471: 45–50.
22. Cai H, Wilcken DEL, Wang XL. The Glu-298 ⇉ Asp (894G ⇉ T) mutation at exon 7 of the endothelial nitric oxide synthase gene and coronary artery disease. J Mol Med 1999; 77: 511–514.
23. Schneider MP, Erdmann J, Delles C, Fleck E, Regitz-Zagrosek V, Schmieder R.E., Functional gene testing of the Glu298Asp polymorphism of the endothelial NO synthase. J Hypertens 2000; 18: 1767–1773.